Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer
- First Posted Date
- 2008-05-01
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 11
- Registration Number
- NCT00670397
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment
Phase 1
Completed
- Conditions
- Unspecified Adult Solid Tumor, Protocol SpecificLymphoproliferative DisorderSmall Intestine CancerLymphoma
- First Posted Date
- 2008-03-28
- Last Posted Date
- 2011-03-02
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 7
- Registration Number
- NCT00646139
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma
Phase 2
Terminated
- Conditions
- Colorectal Cancer
- Interventions
- Dietary Supplement: selenomethionineOther: laboratory biomarker analysisOther: pharmacological studyProcedure: adjuvant therapyProcedure: neoadjuvant therapyProcedure: therapeutic conventional surgeryRadiation: radiation therapy
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 5
- Registration Number
- NCT00625183
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2017-10-12
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 28
- Registration Number
- NCT00612560
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Phase 1
Withdrawn
- Conditions
- Lung Cancer
- First Posted Date
- 2007-11-19
- Last Posted Date
- 2022-10-03
- Lead Sponsor
- Roswell Park Cancer Institute
- Registration Number
- NCT00560495
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy
Not Applicable
Withdrawn
- Conditions
- Prostate Cancer
- First Posted Date
- 2007-11-16
- Last Posted Date
- 2013-02-01
- Lead Sponsor
- Roswell Park Cancer Institute
- Registration Number
- NCT00559481
DNA Changes That Affect Vitamin D Metabolism in Patients With Colorectal Cancer Receiving Vitamin D Supplements
Not Applicable
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Dietary Supplement: cholecalciferolGenetic: polymerase chain reactionGenetic: polymorphism analysisGenetic: protein expression analysisGenetic: reverse transcriptase-polymerase chain reactionGenetic: western blottingOther: high performance liquid chromatographyOther: laboratory biomarker analysisOther: pharmacological studyProcedure: adjuvant therapyProcedure: immunoscintigraphy
- First Posted Date
- 2007-10-30
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 50
- Registration Number
- NCT00550563
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
Fentanyl With or Without Bupivacaine in Reducing Pain in Patients Undergoing Video-Assisted Chest Surgery
Not Applicable
Completed
- Conditions
- Perioperative/Postoperative ComplicationsPain
- Interventions
- First Posted Date
- 2007-10-02
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 30
- Registration Number
- NCT00538499
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer
Phase 1
Terminated
- Conditions
- Stage IV Prostate CancerStage III Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma
- Interventions
- Dietary Supplement: CalcitriolOther: Laboratory Biomarker AnalysisOther: Pharmacological Study
- First Posted Date
- 2007-09-28
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 51
- Registration Number
- NCT00536991
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States
High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
Not Applicable
Completed
- Conditions
- Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Adult Nasal Type Extranodal NK/T-cell LymphomaChildhood Acute Lymphoblastic Leukemia in Remission
- Interventions
- Radiation: total-body irradiationProcedure: autologous-autologous tandem hematopoietic stem cell transplantationProcedure: autologous hematopoietic stem cell transplantation
- First Posted Date
- 2007-09-28
- Last Posted Date
- 2021-04-22
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 174
- Registration Number
- NCT00536601
- Locations
- ๐บ๐ธ
Roswell Park Cancer Institute, Buffalo, New York, United States